Venus Remedies Limited has informed the Exchange regarding a press release dated October 26, 2023, titled "Venus Remedies Granted Market Authorization for Bleomycin 15,000 IU in the United Kingdom".
Venus Remedies Limited has informed the Exchange regarding a press release dated October 26, 2023, titled "Venus Remedies Granted Market Authorization for Bleomycin 15,000 IU in the United Kingdom".